Community-Acquired Pneumonia: Treatment and Best Practices in 2026 *ACPE-Accredited*
CorConsult Rx: Evidence-Based Medicine and Pharmacy
This episode addresses community-acquired pneumonia (CAP), focusing on updated guidelines for treatment and diagnosis. The discussion highlights changes in antibiotic duration, advocating for shorter courses (3-5 days) for stable patients and longer courses only for severe cases. The speakers emphasize avoiding antibiotics for confirmed viral pneumonia and caution against routine corticosteroid use in non-severe cases. Lung ultrasound is presented as an acceptable alternative to chest x-rays for diagnosis. They review antibiotic options based on patient health, comorbidities, and risk factors for resistant bacteria like MRSA and Pseudomonas, detailing appropriate empiric treatments and de-escalation strategies.
Part 1: Introduction, Guidelines, Basics
Part 2: Severity Assessment, Risk Factors
Part 3: Antibiotic Pharmacology, Clinical Pearls
Part 4: Inpatient, Severe Cases, Viral Management
Sign in to continue reading, translating and more.
Open full episode in Podwise
